$RXMD - Progressive Care Achieves Record COVID-19 Testing Revenues BY GlobeNewswire — 7:00 AM ET 04/05/2021 MIAMI, FL, April 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. ( RXMD Loading... Loading... ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has surpassed $1 million in revenues directly driven by its COVID-19 testing program.
“We are truly grateful for the opportunity to be a part of the solution and help our community confront what promises to be a long-term battle with the virus, an elusive and formidable adversary,” commented Alan Jay Weisberg, CEO and Chairman of Progressive Care ( RXMD Loading... Loading... ).
During 2020, the Company conducted over 4,700 COVID-19 tests that resulted in $599k in revenues. For the three months ended March 31, 2020, the revenue run rate associated with COVID-19 testing has accelerated, with approximately 2,900 tests, resulting in over $400k in revenues related to testing.
Mr. Weisberg continued, “We have recently added more testing equipment and analyzers and we hold a market-leading position in rapid results PCR and antigen-based testing systems. We are looking forward to continuing to expand our market share in COVID-19 testing throughout Florida State.”
For more information about Progressive Care ( RXMD Loading... Loading... ), please visit the company’s website. Connect and stay in touch with us on social media:
News 
Market Data 
Discover 
